It's time to end "pay-for-delay" deals
Too often, generic and name-brand prescription drug makers strike deals to postpone generic medications and keep competition out of the marketplace, costing us, as consumers and patients, an estimated $3.5 billion each year in higher drug prices.
Tell your governor: It's time to end pay-for-delay.